55,820 Shares in Haleon PLC Sponsored ADR $HLN Bought by SmartHarvest Portfolios LLC

SmartHarvest Portfolios LLC purchased a new stake in Haleon PLC Sponsored ADR (NYSE:HLN) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 55,820 shares of the company’s stock, valued at approximately $564,000.

A number of other institutional investors have also modified their holdings of the stock. Stance Capital LLC purchased a new stake in shares of Haleon in the third quarter worth about $34,000. Geneos Wealth Management Inc. raised its position in Haleon by 33.0% during the first quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock valued at $50,000 after acquiring an additional 1,203 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in Haleon by 428.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 6,321 shares of the company’s stock valued at $57,000 after acquiring an additional 5,124 shares during the period. Assetmark Inc. lifted its holdings in Haleon by 26.6% in the fourth quarter. Assetmark Inc. now owns 5,962 shares of the company’s stock valued at $60,000 after acquiring an additional 1,252 shares during the period. Finally, Atlantic Union Bankshares Corp boosted its position in Haleon by 69.4% in the 4th quarter. Atlantic Union Bankshares Corp now owns 6,264 shares of the company’s stock worth $63,000 after purchasing an additional 2,567 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Wall Street Analysts Forecast Growth

HLN has been the subject of several recent research reports. Argus raised shares of Haleon to a “strong-buy” rating in a report on Tuesday, March 17th. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Haleon in a research report on Thursday, April 30th. Finally, Wall Street Zen raised shares of Haleon from a “hold” rating to a “buy” rating in a report on Saturday, March 21st. Two investment analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Haleon has an average rating of “Moderate Buy”.

Haleon Stock Down 0.4%

Shares of HLN opened at $9.05 on Friday. The firm has a market cap of $40.06 billion, a P/E ratio of 23.19, a PEG ratio of 2.07 and a beta of 0.13. Haleon PLC Sponsored ADR has a 12 month low of $8.65 and a 12 month high of $11.28. The stock’s 50 day moving average is $9.36 and its two-hundred day moving average is $9.91. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 0.47.

Haleon (NYSE:HLN) last announced its earnings results on Saturday, February 14th. The company reported $6.32 earnings per share (EPS) for the quarter. The business had revenue of $3.65 billion for the quarter. Analysts predict that Haleon PLC Sponsored ADR will post 0.56 earnings per share for the current fiscal year.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over?the?counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self?care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.